September 3, 2025September 3, 2025 Tata Electronics and Merck signed a Memorandum of Understanding (MoU) on 2nd September to strengthen India’s semiconductor capabilities. The partnership focuses on semiconductor materials, fabrication infrastructure, and distribution of speciality chemicals and gases. Merck will provide Tata Electronics with high-purity materials, advanced gas and…
Merck & Co., Inc. NYSE: MRK is one of the largest pharmaceutical firms in the world. The firm ranks fourth behind giants like Eli Lilly NYSE: LLY and Novo Nordisk NYSE: NVO, with a market capitalization of $294 billion. The company’s forward price-to-earnings (P/E) ratio sits at 13x. Compared to a peer group of the…
MRK Merck & Co., Inc. $114.48 +0.81 (+0.71%) (As of 08/19/2024 ET) 52-Week Range $99.14 ▼ $134.63 Dividend Yield 2.69% P/E Ratio 127.20 Price Target $134.58 Global big pharmaceutical company Merck & Co. Inc. NYSE: MRK shares sank 9% following its Q2 2024 earnings release. Merck beat top and bottom line estimates, but the lowered full-year…
$90.15 +3.31 (+3.81%) (As of 03:08 PM ET) 52-Week Range $62.55 ▼ $170.47 Price Target $124.07 Biotechnology company Moderna Inc. NASDAQ: MRNA stock rocked investors with a 30% drop following its second-quarter 2024 earnings release. The company disappointed investors when it revised its respiratory franchise revenue forecast lower by half a billion dollars. However, shares were…